Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-10-08
1995-11-07
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546121, C07D47104, A61K 3144
Patent
active
054648432
ABSTRACT:
A class of imidazo[1,2-a]pyridinyldiacid compounds is described for cognitive enhancement and for treatment of cognitive disorders and which have activity as a cognitive enhancer. Such compounds are also useful to reduce neurotoxic injury associated with anoxia or ischemia which typically follows stroke, cardiac arrest or perinatal asphyxia. The treatment includes administration of a compound of this class alone or in a composition in an amount effective as an agonist or partial agonist to modulate, or as an antagonist to inhibit, excitotoxic actions at major neuronal excitatory amino acid receptor sites. Compounds of most interest are those of the formula: ##STR1## wherein each R.sup.20 is independently selected from hydrogen, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and cycloheptyl; wherein each of Y.sub.m and Y.sub.n is a spacer group selected from methylene and ethylene radicals; wherein m is an integer of one or two; wherein n is an integer of from zero to two; wherein X is one or more groups independently selected from hydrogen, alkyl, cycloalkyl, halo, haloalkyl, hydroxy, hydroxyalkyl, alkoxy, alkoxyalkyl and alkanoyl; or a pharmaceutically-acceptable salt thereof.
REFERENCES:
patent: 3359582 (1970-11-01), Ferrari et al.
patent: 4233301 (1980-11-01), Baldwin et al.
patent: 4330543 (1982-05-01), Baldwin et al.
patent: 4408047 (1983-10-01), Baldwin et al.
patent: 4450164 (1984-05-01), Bristol et al.
patent: 4501745 (1985-02-01), Kaplan et al.
patent: 4650796 (1987-03-01), George et al.
patent: 4997821 (1991-03-01), Cordi et al.
S. M. Rothman et al, Ana Neurol, 19:105-111, 1986.
J. W. Johnson et al, Nature, 325:529-531, 1987.
D. Graham et al, Biochemistry, 24:990-994, 1985.
H. Kishimoto et al, Jour. of Neuro., 37(4):1015-1024, 1981.
L. Nguyen et al, Excit.Amino Acids: Receptor.II, Abstract No. 209.16.
J. B. Monahan et al, Pharm. Bio. & Behav., 34:649-653, 1989.
G. E. Handelmann et al, Pharm. Bio. & Behav., 34:823-828, 1989.
S. I. Deutsch et al, Clin. Neuro., 12(1): 1-13, 1989.
P. C. Contreras et al, Mole. Neurobio., 1:191-211, 1987.
C. Casagrande et al, I1. Farmaco-Ed. Sc., 23:1141-1148, 1968.
Hansen, Jr. Donald W.
Monahan Joseph B.
Peterson Karen B.
Bulock Joseph W.
G.D. Searle & Co.
Keane J. Timothy
Rotman Alan L.
LandOfFree
Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancemen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancemen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancemen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-197470